Structure-activity analysis of anandamide analogs: Relationship to a cannabinoid pharmacophore

Journal of Medicinal Chemistry

Volumn 39, Issue 2, 1996, Pages 471-479

  Thomas, Brian F ^a   Adams, Irma B ^b   Mascarella, S Wayne ^a   Martin, Billy R ^b   Razdan, Raj K ^c  

^a RTI INTERNATIONAL   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ORGANIX INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANANDAMIDE; CANNABINOID RECEPTOR; CANNABIS; DRONABINOL; DRUG CARRIER; ETHANOLAMINE DERIVATIVE; ICOSAPENTAENOIC ACID;

ANIMAL EXPERIMENT; ARTICLE; DRUG CONFORMATION; DRUG POTENCY; FATTY ACID DESATURATION; LOCOMOTION; MOLECULAR DYNAMICS; MOLECULAR MODEL; MOUSE; NONHUMAN; STRUCTURE ACTIVITY RELATION; TAIL FLICK TEST;

ANIMALS; ARACHIDONIC ACIDS; BEHAVIOR, ANIMAL; MICE; MODELS, MOLECULAR; MOLECULAR CONFORMATION; POLYUNSATURATED ALKAMIDES; STRUCTURE-ACTIVITY RELATIONSHIP; TETRAHYDROCANNABINOL;

EID: 0030058353     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9505167     Document Type: Article

References (27)

1. Devane, W. A.; Hanus, L.; Breuer, A.; Pertwee, R. G.; Stevenson, L. A.; Griffin, G.; Gibson, D.; Mandelbaum, A.; Etinger, A.; Mechoulam, R. Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor. Science 1992, 258, 1946-1949.
2. Vogel, Z.; Barg, J.; Levy, R.; Saya, D.; Heldman, E.; Mechoulam, R. Anandamide, a Brain Endogenous Compound, Interacts Specifically with Cannabinoid Receptors and Inhibits Adenylate Cyclase. J. Neurochem. 1993, 61, 352-355.
3. Felder, C. C.; Briley, E. M.; Axelrod, J.; Simon, J. T.; Mackie, K.; Devane, W. A. Anandamide, an Endogenous Cannabimimetic Eicosanoid, Binds to the Cloned Human Cannabinoid Receptor and Stimulates Receptor-Mediated Signal Transduction. PNAS 1993, 90, 7656-7660.
4. Fride, E.; Mechoulam, R. Pharmacological Activity of the Cannabinoid Receptor Agonist, Anandamide, a Brain Constituent. Eur. J. Pharmacol. 1993, 231, 313-314.
5. Smith, P. B.; Compton, D. R.; Welch, S. P.; Razdan, R K.; Mechoulam, R.; Martin, B. R. The Pharmacological Activity of Anandamide, a Putative Endogenous Cannabinoid, in Mice. J. Pharmacol Exp Ther 1994, 270, 219-227.
6. Adams, I. B.; Ryan, W.; Singer, M.; Thomas, B. F.; Compton, D. R.; Razdan, R. K.; Martin, B. R. Evaluation of Cannabinoid Receptor Binding and In-Vivo Activities for Anandamide Analogs. J. Pharmacol. Exp. Ther. 1995, 273, 1172-1181.
7. Crawley, J. N.; Corwin, R. L.; Robinson, J. K.; Felder, C. C.; Devane, W. A.; Axelrod, J. Anandamide, an Endogenous Ligand of the Cannabinoid Receptor, Induces Hypomotility and Hypothermia In Vivo in Rodents. Pharmacol. Biochem. Behav. 1993, 46, 967-972.
8. Hanus, L.; Gopher, A.; Almog, S.; Mechoulam, R. Two New Unsaturated Fatty Acid Ethanolamides in Brain that Bind to the Cannabinoid Receptor. J. Med. Chem. 1993, 36, 3032-3034.
9. Pinto J. C.; Potie, F.; Rice, K. C.; Boring, D.; Johnson, M. R., Evans, D. M.; Wilkin, G. H.; Cantrell, C. H.; Howlett, A. C. Cannabinoid Receptor Binding and Agonist Activity of Amides and Esters of Arachidonic Acid. Mol. Pharmacol. 1994, 46, 516-522.
10. Abadji, V.; Lin, S.; Taha, G.; Griffin, G.; Stevenson, L. A , Pertwee, R. G.; Makriyannis, A. (R)-Methanandamide: a Chiral Novel Anandamide Possessing Higher Potency and Metabolic Stability. J. Med. Chem. 1994, 37, 1889-1893.
11. Binder, M.; Franke I. Is there a Cannabinoid Receptor? Current Perspectives and Approaches to the Elucidation of the Molecular Mechanism of Action of the Psychotropic Constituents of Cannabis sativa L. In Neuroreceptors; Hucho, F., Ed.; Walter de Gruyter: Berlin, 1982; pp 151-161.
12. Razdan, R. K. Structure-Activity Relationships in the Cannabinoids. Pharm. Rev. 1986, 38, 75-149.
13. Reggio, P. H.; Greer, K. W.; Cox, S. M. The Importance of the Orientation of the C9 Substituent to Cannabinoid Activity. J. Med. Chem. 1989, 32, 1630-1635.
14. 911-Tetrahydrocannabinols in Solution using High Resolution Nuclear Magnetic Resonance Spectroscopy. Mol Pharmacol. 1989, 35, 495-503.
15. Thomas, B. F.; Compton, D. R.; Martin, B. R.; Semus, S. F. Modeling the Cannabinoid Receptor: A Three-Dimensional Quantitative Structure-Activity Analysis. Mol Pharmacol. 1991, 40, 656-665.
16. Milne, G. M.; Johnson, M. R. Levonantradol: a Role for Central Prostanoid Mechanisms. J. Clin, Pharmacol. 1981, 21, 367S
17. Johnson, M. R.; Melvin, L. S. The Discovery of Nonclassical Cannabinoid Analgetics. In Cannabinoids as Therapeutic Agents; CRC Press: Boca Raton, FL, 1986; pp 121-145
18. Devane, W. A.; Dysarz, F. A.; Johnson, M. R.; Melvin, L. S.; Howlett, A. C. Determination and Characterization of a Cannabinoid Receptor in Rat Brain. Mol. Pharmacol. 1988, 34, 605-613.
19. Rich, M R. Conformational Analysis of Arachidonic and Related Fatty Acids using Molecular Dynamics Simulations. Biochim. Biophys. Acta 1993, 1178, 87-96.
20. Corey, E. J.; Niwa, H.; Falck, J. R. Selective Epoxidation of Eicosa-cis 5,8,11,14-tetraenoic (Arachidonic) Acid and Eicosa-cis-8,11,14-trienoic Acid. J. Am. Chem. Soc 1979, 101, 1586-1587.
21. Corey, E. J.; Iguchi, S.; Albright, J. O., De, B. Studies on the Conformational Mobility of Arachidonic Acid: Facile Macrolactonization of 20-Hydroxyarachidonic Acid. Tetrahedron Lett. 1983, 24, 37.
22. Reggio, P. H. Molecular Determinants of Cannabinoid Activity: Toward the Design of Cannabinoid Analgesics with Reduced Psychoactive Liability. Natl. Inst. Drug Abuse Res. Monogr. 1993, 134, 210-228.
23. Thibaut, U.; Folkers, G.; Klebe, G.; Kubinyi, H.; Merz, A.; Rognan, D. Recommendations for CoMFA Studies and 3D QSAR Publications. In 3D QSAR in Drug Design. Theory, Methods and Applications; Kubinyi, H., Ed., ESCOM: Leiden, 1993; pp 711-716.
24. Melvin, L. S.; Johnson, M. R.; Harbert, C. A.; Milne, G. M.; Weissman, A. A Cannabinoid Derived Prototypical Analgesic. J. Med. Chem. 1984, 27, 67-71.
25. Reggio, P. H. Molecular Determinants for Cannabinoid Activity: Refinement of a Molecular Reactivity Template. Natl. Inst. Drug Abuse Res Monogr. 1987, 79, 82-95.
26. Huffman, J. W.; Dai, D. Design, Synthesis and Pharmacology of Cannabimimetic Indoles. Biomed. Chem. Lett. 1994, 4, 563-566.
27. Melvin, L. S.; Milne, G. M.; Johnson, M. R.; Subramaniam, B.; Wilken, G. H.; Howlett, A. C. Structure-Activity Relationships for Cannabinoid Receptor-Binding and Analgesic Activity: Studies of Bicyclic Cannabinoid Analogs. Mol. Pharmacol. 1993, 44, 1008-1015.